These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11382762)

  • 1. Evidence for a distinct inhibitory factor in the regulation of p53 functional activity.
    Wiederschain D; Gu J; Yuan ZM
    J Biol Chem; 2001 Jul; 276(30):27999-8005. PubMed ID: 11382762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.
    Calabrò V; Mansueto G; Parisi T; Vivo M; Calogero RA; La Mantia G
    J Biol Chem; 2002 Jan; 277(4):2674-81. PubMed ID: 11714701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.
    Zhang L; Nie L; Maki CG
    Mol Cancer; 2006 Dec; 5():68. PubMed ID: 17150106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
    Das S; El-Deiry WS; Somasundaram K
    J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73.
    Stiewe T; Stanelle J; Theseling CC; Pollmeier B; Beitzinger M; Pützer BM
    J Biol Chem; 2003 Apr; 278(16):14230-6. PubMed ID: 12584188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
    Mondal N; Parvin JD
    Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.
    Stiewe T; Theseling CC; Pützer BM
    J Biol Chem; 2002 Apr; 277(16):14177-85. PubMed ID: 11844800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis.
    Zeng X; Li X; Miller A; Yuan Z; Yuan W; Kwok RP; Goodman R; Lu H
    Mol Cell Biol; 2000 Feb; 20(4):1299-310. PubMed ID: 10648616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SSRP1 functions as a co-activator of the transcriptional activator p63.
    Zeng SX; Dai MS; Keller DM; Lu H
    EMBO J; 2002 Oct; 21(20):5487-97. PubMed ID: 12374749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 family members: similar biochemistry, different biology.
    Barbieri CE; Pietenpol JA
    Cancer Biol Ther; 2005 Apr; 4(4):419-20. PubMed ID: 15908776
    [No Abstract]   [Full Text] [Related]  

  • 14. The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells.
    Nahor I; Abramovitch S; Engeland K; Werner H
    Growth Horm IGF Res; 2005 Dec; 15(6):388-96. PubMed ID: 16181796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.
    Johnson RA; Shepard EM; Scotto KW
    J Biol Chem; 2005 Apr; 280(14):13213-9. PubMed ID: 15634666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of functions within the p53/p63/p73 family.
    De Laurenzi V; Melino G
    Ann N Y Acad Sci; 2000; 926():90-100. PubMed ID: 11193045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 and MDMX can interact differently with ARF and members of the p53 family.
    Wang X; Arooz T; Siu WY; Chiu CH; Lau A; Yamashita K; Poon RY
    FEBS Lett; 2001 Feb; 490(3):202-8. PubMed ID: 11223036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional impairment of p73 and p51, the p53-related proteins, by the human T-cell leukemia virus type 1 Tax oncoprotein.
    Kaida A; Ariumi Y; Ueda Y; Lin JY; Hijikata M; Ikawa S; Shimotohno K
    Oncogene; 2000 Feb; 19(6):827-30. PubMed ID: 10698501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminal sterile alpha motif and the extreme C terminus regulate the transcriptional activity of the alpha isoform of p73.
    Liu G; Chen X
    J Biol Chem; 2005 May; 280(20):20111-9. PubMed ID: 15769743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
    Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
    J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.